Navigation Links
AMRI Hires Vijay Kumar Batra as Managing Director, AMRI India
Date:1/10/2014

ALBANY, N.Y., Jan. 10, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) today announced the appointment of Vijay Kumar Batra, to the position of Managing Director, AMRI India, effective January 2, 2014. Mr. Batra will report to Steve Hagen, Ph.D., Senior Vice President of Manufacturing and Pharmaceuticals.

"Mr. Batra brings a wealth of experience in the Active Pharmaceutical Ingredients (APIs) and intermediates business and he also brings a leadership acumen that helps AMRI continue our plan for growth in the Indian and world markets," said Dr. Hagen. "We are excited to have Vijay on our leadership team. He has a strong record of leading business growth in the area of API and intermediates and is highly respected by those who have worked with him and the businesses he has led."

Before coming to AMRI, Mr. Batra held a number of executive roles with Teva Pharmaceuticals Industries Ltd. since 2003. Most recently, he was Vice Chairman and Managing Director, Teva API India, responsible for research and development and manufacturing of API's and advanced intermediates for the global market. The facilities overseen by Mr. Batra had strong compliance records and achieved U.S. Food and Drug Administration and other international certifications. Mr. Batra also served as Chairman of Teva API China during his most recent tenure. Prior to these roles, Mr. Batra was President and Director of JK Drugs and Pharmaceuticals and Advisor at JK Pharmachem Ltd. He also held other roles with Ranbaxy, Kinetics Technology India Ltd., and Synthetics and Chemicals Ltd. Mr. Batra was also responsible for Drug Product Manufacturing and was Vice Chairman of Tevapharm India Pvt. Ltd. during his last few years.

Mr. Batra earned a Bachelor's degree in Technology from the Indian Institute of Technology and is an alumnus of the Wharton Business School's Senior Executive Development program.

About AMRI
Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development and manufacturing services. For over 22 years, AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers with informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal).


'/>"/>
SOURCE AMRI
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. FPR Specialty Pharmacy Hires Slomski To Lead Sales And Marketing; Moves To Next Phase In Cleveland Clinic Trials
2. inviCRO hires Stefan Linehan as Director of Ex Vivo Research & Imaging Services
3. Xcelience hires Clinical Supplies VP; Opens Birmingham, UK Site
4. Preventice hires Kevin Nickels as chief operating officer
5. Medolac Hires Doug Hawkins as Senior Executive
6. Spectrum Orthotics And Prosthetics Hires New Practitioner
7. SynGen Hires Former Pall Medical Executive as President of Cord Blood Business Unit
8. BioSante Hires VP of New Business Development and Contract Manufacturing and Announces New Appointment to Board of Directors
9. Tris Pharma Hires President for Generic Pharmaceuticals Business
10. United Medical Credit Hires More Staff to Contact Doctors and Promote their Financing Services
11. Swisse Wellness Australia Hires MWW As Public Relations Agency Of Record For U.S. Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... 2016 TARE (Transarterial Radio-embolization) ... Savings and Overall Decreased Use of Hospital ... international specialist healthcare company, has today announced the ... Meeting of ISPOR (International Society for Pharmacoeconomics and ... (HCC) using yttrium-90 glass microspheres is associated with ...
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... 27, 2016 , ... An educational campaign aimed at everyone ... courtesy of awareness-driven celebrities and thought leaders. It also provides insight to the ... leaders such as Bioness. , As patients feel increasingly concerned about the ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Aimed at ... human interest stories, which come courtesy of leaders in the nursing and health care ... from leading advocates and associations—namely Abilene Christian University. , As the nursing industry ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook a ... (NHDSC) suggests that Americans prefer their dogs straight off the grill. Of the 90 ... their favorite way to cook a hot dog, far outpacing other cooking methods such ...
(Date:5/26/2016)... Atlanta, Georgia (PRWEB) , ... May 26, 2016 ... ... a certificate in intellectual property (IP) to its specialty academic programs. , Answering ... joins the college’s existing certificate programs in health law, and environmental and land ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
Breaking Medicine News(10 mins):